Pedram Sameni > News

The intellectual property landscape constantly evolves, with the U.S. Court of Appeals for the Federal Circuit (CAFC) serving as a central forum in ... Read More »

In a move that reshapes the IP landscape, FisherBroyles has expanded its IP Practice Group by welcoming Browdy & Neimark’s... Read More »

Intellectual property litigation is becoming increasingly competitive, with the Patent Trial and Appeal Board (PTAB) serving as a critical venue... Read More »

Recently launched, Patexia’s 2024 PTAB Intelligence Report provides a detailed analysis of the latest trends and developments in the ... Read More »

Patexia has recently launched its 2024 PTAB Intelligence Report, offering a detailed analysis of the latest trends and developments in Patent Trial ... Read More »

The competitive landscape of ANDA litigation has played a significant role in shaping the pharmaceutical industry, showcasing the legal experts who ... Read More »

The intellectual property landscape is constantly evolving, with Patent Trial and Appeal Board (PTAB) proceedings continuing to serve as a central... Read More »

In the pharmaceutical industry, innovation drives progress, but intense legal battles, particularly in ANDA (Abbreviated New Drug... Read More »

In a significant patent infringement case, a California jury awarded MR Technologies (MRT) $262 million in damages against Western... Read More »

The sixth edition of the Patent Intelligence Report, released in March this year, provides an in-depth analysis of  the patent prosecution... Read More »

When several ANDA filers seek approval for the same drug, a branded pharmaceutical company may struggle to bring Hatch-Waxman Act patent... Read More »

In April, we released the fourth edition of the Trademark Intelligence Report, providing an in-depth analysis of trademark filing and registration... Read More »

In the rapidly evolving landscape of innovation, law firms play a critical role in safeguarding and advancing technological progress. They guide... Read More »

Revlimid (lenalidomide), developed by Celgene Corporation, has been a groundbreaking treatment for multiple myeloma, myelodysplastic... Read More »

Patents and trademarks are foundational to the U.S. economy, fostering innovation, creating jobs, and driving economic growth. As the landscape of... Read More »

The landscape of patent litigation has seen significant shifts over the past five years, and the first half of 2024 makes no exception presenting... Read More »

Earlier this year, in March, we published our Patent Intelligence Report 2024. This is a comprehensive summary of the patent landscape, designed to ... Read More »

In an ever-evolving global marketplace, trademarks serve as critical tools for businesses to protect, differentiate, and optimize their unique... Read More »

The patent litigation dispute of Apple v. Samsung was a landmark legal battle involving multiple trials and appeals. Before their patent... Read More »

Understanding the trends of the trademark industry is vital for developing strategies but also for maintaining a competitive edge. We released our... Read More »